SCHEMBL23919280

SCHEMBL23919280

CCc1ccc2c(oc3ccccc32)c1N(c1ccccc1C)c1ccc2ccc3c(N(c4ccccc4C)c4c(CC)ccc5c4oc4ccccc45)ccc4ccc1c2c43

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.34
ALOX5 P09917 1/20 0.33
ALDH1A1 P00352 5/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
PKM P14618 1/20 0.33
GLA P06280 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
THRB P10828 1/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PSMD14 O00487 1/20 0.31
POLB P06746 1/20 0.31
RECQL P46063 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919275 0.88 ALOX5 (0.35) ALOX5ALDH1A1L3MBTL1GLASMN1; SMN2
SCHEMBL22382119 0.88 PGR (0.33) TP53ALDH1A1L3MBTL1SMN1; SMN2THRB
SCHEMBL23919272 0.85 ALOX5 (0.32) ALOX5ALDH1A1L3MBTL1GLASMN1; SMN2
SCHEMBL23131471 0.83 HPGD (0.33) TP53ALDH1A1L3MBTL1SMN1; SMN2TSHR
SCHEMBL23919268 0.83 ALDH1A1 (0.37) TP53ALOX5ALDH1A1L3MBTL1PKM
SCHEMBL4089236 0.83 HPGD (0.34) TP53ALOX5ALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL23919259 0.83 TDP1 (0.30) TP53L3MBTL1NPSR1MEN1KMT2A
SCHEMBL23919291 0.83 TP53 (0.33) TP53ALOX5SMN1; SMN2NPSR1MEN1
SCHEMBL23919281 0.82 MEN1 (0.32) ALOX5ALDH1A1L3MBTL1GLAMAPT
SCHEMBL12206527 0.82 HPGD (0.34) TP53ALOX5ALDH1A1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 TP53 3762/4885ALOX5 4667/4885ALDH1A1 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.